Amazon already is a leader in most e-commerce and digital entertainment categories, and their partnership with Whole Foods has had a lot of speculation on the future of supermarkets. Paul Mampilly, a chief editor at Banyan Hill has informed readers about Amazon’s new partnership with Berkshire Hathaway and JP Morgan Chase and how this is funding a new way to buy prescription drugs that is causing a major disruption to the pharmaceutical industry. Many healthcare stocks have seen their margins go down, so Mampilly warns investors to take care when considering buying cheap stocks or ETFs. He does have words of optimism in that there have been companies such as Netflix and Kroger who have found ways to beat Amazon’s systems, and he says some drug store chains like CVS just might do the same.
Paul Mampilly had the understanding of the markets to see the dot-com crash of 2000 and the real estate bubble of 2008 happen before they did. He spent years lending his knowledge of the markets and offering top advisory services as a manager at several large banks including ING, Deutsche Bank and Banker’s Trust. Paul Mampilly was also a featured financier in Barron’s magazine in 2006 when he took over asset management at Kinetics International Fund, one of the top hedge funds at the time. He grew that hedge fund from $6 billion to $25 billion, and a couple years later he won a competition run by the Templeton Foundation in which he bought stocks with $50 million during the real estate crisis, and then made 76℅ in gains without shorting or buying high risk stocks. In 2012 Mampilly made news for predicting the boom of Sarepta Therapeutics and saw its stock grow very large.
Paul Mampilly eventually left Wall Street because he was never truly happy with his long work hours and only making money for the wealthy 1℅. So he began writing newsletters for Banyan Hill that readers from all backgrounds have been able to understand and learn how they can build wealth without needing a professional broker. Mampilly also writes free posts in Banyan Hill’s Daily Investor Sovereign.
For details: www.talkmarkets.com/contributor/Paul-Mampilly/